FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Oates

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Anatomy

Co-author Network

Publications

TOP 3
H Liu; Y Luo; T Zhang; Y Zhang; Q Wu; L Yuan; S S M Chung; Peter Oates; James Y Yang
Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice.
Longxin Qiu; Xiaochun Wu; Jenny F L Chau; Irene Y Y Szeto; Terence Tam; Zongsheng Guo; Sookja K Chung; Peter Oates; Stephen S M Chung; James Y Yang
Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis.
Bingmei Yang; Andrea D Hodgkinson; Peter Oates; Beverley A Millward; Andrew G Demaine
High glucose induction of DNA-binding activity of the transcription factor NFkappaB in patients with diabetic nephropathy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Oates (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: H Liu; Y Luo; T Zhang; Y Zhang; Q Wu; L Yuan; S S M Chung; Peter Oates; James Y Yang
Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice.
Diabetologia 2011;54(5):1242-51.
2008: Longxin Qiu; Xiaochun Wu; Jenny F L Chau; Irene Y Y Szeto; Terence Tam; Zongsheng Guo; Sookja K Chung; Peter Oates; Stephen S M Chung; James Y Yang
Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis.
The Journal of biological chemistry 2008;283(25):17175-83.
2008: Bingmei Yang; Andrea D Hodgkinson; Peter Oates; Beverley A Millward; Andrew G Demaine
High glucose induction of DNA-binding activity of the transcription factor NFkappaB in patients with diabetic nephropathy.
Biochimica et biophysica acta 2008;1782(5):295-302.
2008: Peter Oates
Aldose reductase, still a compelling target for diabetic neuropathy.
Current drug targets 2008;9(1):14-36.
2006: Keerthi Thamotharampillai; Albert K F Chan; Bruce Bennetts; Maria E Craig; Janine Cusumano; Martin Silink; Peter Oates; Kim C Donaghue
Decline in neurophysiological function after 7 years in an adolescent diabetic cohort and the role of aldose reductase gene polymorphisms.
Diabetes care 2006;29(9):2053-7.
2006: Bingmei Yang; Andrea D Hodgkinson; Peter Oates; H Moo Kwon; Beverley A Millward; Andrew G Demaine
Elevated activity of transcription factor nuclear factor of activated T-cells 5 (NFAT5) and diabetic nephropathy.
Diabetes 2006;55(5):1450-5.
2005: Robert E Schmidt; Denise A Dorsey; Lucie N Beaudet; Curtis A Parvin; Kevin E Yarasheski; Samuel R Smith; Joseph R Williamson; Richard G Peterson; Peter Oates
A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes.
Experimental neurology 2005;192(2):407-19.
2005: Arun Changolkar; Joseph A Hypolite; Michael E DiSanto; Peter Oates; Alan J Wein; Samuel Chacko
Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase.
The Journal of urology 2005;173(1):309-13.
2003: Andrea D Hodgkinson; Tracey Bartlett; Peter Oates; Beverley A Millward; Andrew G Demaine
The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy.
Diabetes 2003;52(3):846-51.
2000: T Nishikawa; Diane Edelstein; Xue-Liang Du; SI Yamagishi; Takeshi Matsumura; Y Kaneda; M A Yorek; D Beebe; Peter Oates; Hans-Peter Hammes; Ida Giardino; Michael Brownlee
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.
Nature 2000;404(6779):787-90.
1997: Ravichandran Ramasamy; Peter Oates; Saul Schaefer
Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
Diabetes 1997;46(2):292-300.
1994: P Xia; Toyoshi Inoguchi; Timothy S Kern; RL Engerman; Peter Oates; George L King
Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia.
Diabetes 1994;43(9):1122-9.
1994: G Pugliese; Ronald G Tilton; A Speedy; Peter Oates; Joseph R Williamson
Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
Metabolism: clinical and experimental 1994;43(4):492-500.
1993: B Tesfamariam; S Gupta; Peter Oates; Neil B Ruderman; Richard A Cohen
Reduced Na(+)-K+ pump activity in diabetic rabbit carotid artery: reversal by aldose reductase inhibition.
The American journal of physiology 1993;265(4 Pt 2):H1189-94.
1993: R Sarges; Peter Oates
Aldose reductase inhibitors: recent developments.
Progress in drug research. Fortschritte der Arzneimittelforschung. Progrès des recherches pharmaceutiques 1993;40():99-161.
1992: William R Meyer; M B Doyle; James A Grifo; K J Lipetz; Peter Oates; Alan H DeCherney; Michael Diamond
Aldose reductase inhibition prevents galactose-induced ovarian dysfunction in the Sprague-Dawley rat.
American journal of obstetrics and gynecology 1992;167(6):1837-43.
1991: J P Hakkinen; W F Holt; C J Goddard; Peter Oates; W R Murphy; J J Maciejko; L A Reiter
CP-66,948: an antisecretory histamine H2-receptor antagonist with mucosal protective properties.
Digestive diseases and sciences 1991;36(12):1721-8.
1988: Peter Oates; J P Hakkinen
Studies on the mechanism of ethanol-induced gastric damage in rats.
Gastroenterology 1988;94(1):10-21.
1986: C A Lipinski; J L LaMattina; Peter Oates
Bioisosteric prototype design of biaryl imidazolyl and triazolyl competitive histamine H2-receptor antagonists.
Journal of medicinal chemistry 1986;29(11):2154-63.
1980: Peter Oates; O Touster
In vitro fusion of Acanthamoeba phagolysosomes. III. Evidence that cyclic nucleotides and vacuole subpopulations respectively control the rate and the extent of vacuole fusion in Acanthamoeba homogenates.
The Journal of cell biology 1980;85(3):804-10.
1978: Peter Oates; O Touster
In vitro fusion of Acanthamoeba phagolysosomes. II Quantitative characterization of in vitro vacuole fusion by improved electron microscope and new light microscope techniques.
The Journal of cell biology 1978;79(1):217-34.
1976: Peter Oates; O Touster
In vitro fusion of Acanthamoeba phagolysosomes. I. Demonstration and quantitation of vacuole fusion in Acanthamoeba homogenates.
The Journal of cell biology 1976;68(2):319-38.